Research Article: On the evolutionary ecology of multidrug resistance in bacteria

Date Published: May 13, 2019

Publisher: Public Library of Science

Author(s): Sonja Lehtinen, François Blanquart, Marc Lipsitch, Christophe Fraser, Erwin Schurr.


Resistance against different antibiotics appears on the same bacterial strains more often than expected by chance, leading to high frequencies of multidrug resistance. There are multiple explanations for this observation, but these tend to be specific to subsets of antibiotics and/or bacterial species, whereas the trend is pervasive. Here, we consider the question in terms of strain ecology: explaining why resistance to different antibiotics is often seen on the same strain requires an understanding of the competition between strains with different resistance profiles. This work builds on models originally proposed to explain another aspect of strain competition: the stable coexistence of antibiotic sensitivity and resistance observed in a number of bacterial species. We first identify a partial structural similarity in these models: either strain or host population structure stratifies the pathogen population into evolutionarily independent sub-populations and introduces variation in the fitness effect of resistance between these sub-populations, thus creating niches for sensitivity and resistance. We then generalise this unified underlying model to multidrug resistance and show that models with this structure predict high levels of association between resistance to different drugs and high multidrug resistance frequencies. We test predictions from this model in six bacterial datasets and find them to be qualitatively consistent with observed trends. The higher than expected frequencies of multidrug resistance are often interpreted as evidence that these strains are out-competing strains with lower resistance multiplicity. Our work provides an alternative explanation that is compatible with long-term stability in resistance frequencies.

Partial Text

Antibiotic resistance and, in particular, multidrug resistance (MDR) are public health threats. Multidrug resistant infections are associated with poorer clinical outcomes and higher cost of treatment than other infections [1, 2] and there is concern that the emergence of pan-resistant strains (pathogens resistant to all available antibiotics) will render some infections untreatable [3].